Patient number | Age | Sex | PGI | PGII | PGI/PGII | Gastrin 17 | Ab anti-HP | HP histology | Ab anti-PC | Atrophya | Stomach locationb |
---|
1 | 70 | F | 22.3 | 17.4 | 1.28 | 103.8 | 87.9 | − | ND | 1 | Antrum |
2 | 37 | F | 25 | 7.26 | 3.44 | 40 | 6.5 | − | + | 2 | Corpus |
3 | 42 | F | 14.8 | 10.9 | 1.36 | 350.8 | 100.8 | + | + | 3 | Corpus |
4c | 40 | F | 107.5 | 10.3 | 10.44 | 2.31 | 97.8 | − | + | 0 | Antrum and corpus |
- Ab anti-HP antibodies against anti-HP; Ab anti-PC, antibodies against parietal cells; anti-HF? antibodies against HP; ND, not determined; PGI, serum pepsinogen I; PGII, serum pepsinogen II.
- aAtrophy scores according to operative link for gastritis assessment (OLGA) system (adapted considering only a simple sample of antral biopsy).
- bStomach location refers to the biopsies from which HP strains were isolated.
- cPatient at the first visit without atrophy, but with increasing anti-PC Ab (levels increasing from 1:160 to 1:1,280 after 1 month) and still under follow-up.